218 related articles for article (PubMed ID: 31342064)
21. Repeat convection-enhanced delivery for diffuse intrinsic pontine glioma.
Bander ED; Ramos AD; Wembacher-Schroeder E; Ivasyk I; Thomson R; Morgenstern PF; Souweidane MM
J Neurosurg Pediatr; 2020 Sep; 26(6):661-666. PubMed ID: 32977309
[TBL] [Abstract][Full Text] [Related]
22. A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas.
Pan C; Zhang M; Xiao X; Kong L; Wu Y; Zhao X; Sun T; Zhang P; Geng Y; Zuo P; Wang Y; Li X; Gu G; Li T; Wu Z; Zhang J; Zhang L
Neurosurg Rev; 2023 Jun; 46(1):151. PubMed ID: 37358632
[TBL] [Abstract][Full Text] [Related]
23. ABC Transporter Inhibition Plus Dexamethasone Enhances the Efficacy of Convection Enhanced Delivery in H3.3K27M Mutant Diffuse Intrinsic Pontine Glioma.
Tsvankin V; Hashizume R; Katagi H; Herndon JE; Lascola C; Venkatraman TN; Picard D; Burrus B; Becher OJ; Thompson EM
Neurosurgery; 2020 May; 86(5):742-751. PubMed ID: 31225627
[TBL] [Abstract][Full Text] [Related]
24. Oncohistone Mutations in Diffuse Intrinsic Pontine Glioma.
Zhang X; Zhang Z
Trends Cancer; 2019 Dec; 5(12):799-808. PubMed ID: 31813457
[TBL] [Abstract][Full Text] [Related]
25. A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survival.
Silva-Evangelista C; Barret E; Ménez V; Merlevede J; Kergrohen T; Saccasyn A; Oberlin E; Puget S; Beccaria K; Grill J; Castel D; Debily MA
Oncogene; 2019 Sep; 38(38):6479-6490. PubMed ID: 31324890
[TBL] [Abstract][Full Text] [Related]
26. Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review.
Dalmage M; LoPresti MA; Sarkar P; Ranganathan S; Abdelmageed S; Pagadala M; Shlobin NA; Lam S; DeCuypere M
J Neurosurg Pediatr; 2023 Dec; 32(6):665-672. PubMed ID: 37724839
[TBL] [Abstract][Full Text] [Related]
27. Diffuse intrinsic pontine gliomas in adults: A retrospective study.
Kandregula S; Konar S; Sadashiva N; Nagesh M; Kalahasti SR; Krishna U; Saini J; Shukla D; Santosh V
Neurol India; 2022; 70(2):584-590. PubMed ID: 35532623
[TBL] [Abstract][Full Text] [Related]
28. Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models.
Martinez-Velez N; Marigil M; García-Moure M; Gonzalez-Huarriz M; Aristu JJ; Ramos-García LI; Tejada S; Díez-Valle R; Patiño-García A; Becher OJ; Gomez-Manzano C; Fueyo J; Alonso MM
Acta Neuropathol Commun; 2019 Apr; 7(1):64. PubMed ID: 31036068
[TBL] [Abstract][Full Text] [Related]
29. Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials.
Vitanza NA; Monje M
Curr Treat Options Neurol; 2019 Jul; 21(8):37. PubMed ID: 31290035
[TBL] [Abstract][Full Text] [Related]
30. Molecular alterations in pediatric brainstem gliomas.
Porkholm M; Raunio A; Vainionpää R; Salonen T; Hernesniemi J; Valanne L; Satopää J; Karppinen A; Oinas M; Tynninen O; Pentikäinen V; Kivivuori SM
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792659
[TBL] [Abstract][Full Text] [Related]
31. Leptomeningeal and subependymal seeding of diffuse intrinsic pontine glioma: a case report.
Parenrengi MA; Prastikarunia R; Suryaningtyas W
Childs Nerv Syst; 2022 Aug; 38(8):1643-1645. PubMed ID: 35290487
[TBL] [Abstract][Full Text] [Related]
32. First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report.
Hall MD; Odia Y; Allen JE; Tarapore R; Khatib Z; Niazi TN; Daghistani D; Schalop L; Chi AS; Oster W; Mehta MP
J Neurosurg Pediatr; 2019 Apr; 23(6):719-725. PubMed ID: 30952114
[TBL] [Abstract][Full Text] [Related]
33.
Zhao X; Li D; Qiao Z; Wang K; Chen Q; Pan C; Wu Y; Xiao D; Xi T; Zhang L; Ai L
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1709-1719. PubMed ID: 36697961
[TBL] [Abstract][Full Text] [Related]
34. A longitudinally extensive H3 K27M-mutant diffuse midline glioma in an elderly patient clinically mimicking central nervous system inflammation: a case report.
Babarczy K; Reisz Z; Szabo E; Rajda C; Vecsei L; Bodi I; Klivenyi P; Hortobagyi T; Szalardy L
Folia Neuropathol; 2020; 58(4):377-385. PubMed ID: 33480242
[TBL] [Abstract][Full Text] [Related]
35. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.
Schreck KC; Ranjan S; Skorupan N; Bettegowda C; Eberhart CG; Ames HM; Holdhoff M
J Neurooncol; 2019 May; 143(1):87-93. PubMed ID: 30864101
[TBL] [Abstract][Full Text] [Related]
36. Indolent course of brainstem tumors with K27M-H3.3 mutation.
Baroni LV; Solano-Paez P; Nobre L; Michaeli O; Hawkins C; Laughlin S; Bartels U; Ramaswamy V; Bouffet E
Pediatr Blood Cancer; 2020 Mar; 67(3):e28102. PubMed ID: 31793190
[TBL] [Abstract][Full Text] [Related]
37. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.
Kleinschmidt-DeMasters BK; Mulcahy Levy JM
Clin Neuropathol; 2018; 37 (2018)(2):53-63. PubMed ID: 29393845
[TBL] [Abstract][Full Text] [Related]
38. Retrospective study of diffuse intrinsic pontine glioma in the Belgian population: a 25 year experience.
Ruttens D; Messiaen J; Ferster A; Piette C; Schifflers S; Van Damme A; van der Werff Ten Bosch J; Verlooy J; Willems L; Jacobs S
J Neurooncol; 2021 Jun; 153(2):293-301. PubMed ID: 33939103
[TBL] [Abstract][Full Text] [Related]
39. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
40. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
